“…Lung injury caused by chemicals and particulate matter: Cadmium-, hydrogen sulfide-, phosgene-NaHS-, diethylenetriamine (NO donor)-, oleic acid-, arsenic trioxide-, particulate matter (PM)2.5-, thrombin-, nocodazole (inducer of microtubule disassembly)-, alcohol-, and ozoneinduced injury in mice and rats, and primary human lung microvascular endothelial cells, A549 cells, human bronchial epithelial (HBEC)-2 and HBEC-3 cells, BEAS-2B cells, primary type II epithelial cells, human bronchial epithelial 16HBE cells, human pulmonary artery endothelial cells, bovine pulmonary arterial endothelial cells, and primary normal human bronchial epithelial cells [44,[225][226][227][228][229][230][231][232][233][234][235] Decrease in ZO-1 and occludin and dysregulation of E-cadherin and N-cadherin Allergic asthma: Aspergillus fumigatus and co-infection with Streptococcus pneumoniae-, and Ovalbumin (OVA)-LPS-induced allergic asthma in mice, and TGF-β-challenged mouse MLE-12 cells [236,237] Decrease in claudin-1, claudin-4, claudin-5, and claudin-10b, ZO-1, ZO-2, occludin, and tricellulin; increase in claudin-2 and claudin-7, and soluble E-cadherin; no change in occludin, claudin-1, claudin-7, and claudin-18, ZO-1, E-cadherin, and β-catenin; disrupted distribution and structure of ZO-1, occludin, and β-catenin Infections: CLP/sepsis-, RSV-, VP1 capsid protein of enterovirus (EV71)-, and influenza-induced lung injury models in mice, primary human lung microvascular endothelial cells, human bronchial epithelial cells from healthy asthmatic patients, and mouse tracheal epithelial cells, lung tissues from HIV-1 seropositive patients with interstitial pneumonitis or bronchopneumonia, and ex vivo perfused human lungs [55, 238-241, 242, 243] Decrease in ZO-1, ZO-2, occludin, claudin-5 and claudin-18, E-cadherin, and VE-cadherin; increased expression of VE-cadherin and ZO-1, and association of ZO-1, α-catenin, VASP, and VE-cadherin; no effect on claudin-1 and -4; increased expression and localization of VE-cadherin; and altered distribution of ZO-1, VE-cadherin, and β-catenin…”